UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Annals of oncology, 2017-05, Vol.28 (5), p.1130-1136

2017

Volltextzugriff (PDF)

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Annals of oncology, 2019-05, Vol.30 (5), p.815-822

2019

Volltextzugriff (PDF)

Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor

Oncogene, 2014-02, Vol.33 (9), p.1158-1166

2014

Volltextzugriff (PDF)

Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma

Annals of oncology, 2024-08, Vol.35 (8), p.739-746

2024

Volltextzugriff (PDF)

The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma

Oncogene, 2014-01, Vol.33 (2), p.236-245

2014

Volltextzugriff (PDF)

Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS

Cell death & disease, 2010-09, Vol.1 (9), p.e69-e69

2010

Volltextzugriff (PDF)

Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

Annals of oncology, 2018-10, Vol.29, p.viii659-viii659

2018

Volltextzugriff (PDF)

PO-368 Differential effects of immune activity on melanoma cell subtypes

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A372-A373

2018

Volltextzugriff (PDF)

Uveal melanoma cell lines depend on multiple signaling pathways for survival

Annals of oncology, 2019-10, Vol.30, p.v6-v7

2019

Volltextzugriff (PDF)

21P - Uveal melanoma cell lines depend on multiple signaling pathways for survival

Annals of oncology, 2019-10, Vol.30, p.v6-v7

2019

Volltextzugriff (PDF)

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization

Oncogene, 2000-06, Vol.19 (26), p.2978-2985

2000

Volltextzugriff (PDF)

21PUveal melanoma cell lines depend on multiple signaling pathways for survival

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding

Clinical cancer research, 2001-10, Vol.7 (10), p.3282-3288

2001

Volltextzugriff (PDF)

Impaired inhibition of NF-κB activity by melanoma-associated p16INK4a mutations

Biochemical and biophysical research communications, 2005-07, Vol.332 (3), p.873-879

2005

Volltextzugriff (PDF)

1861PPre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

Annals of oncology, 2017-09, Vol.28, p.v432-v432

2017

Volltextzugriff (PDF)

A Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D+T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)

Annals of oncology, 2017-09, Vol.28, p.v445-v445

2017

Volltextzugriff (PDF)

p14ARF Interacts with the SUMO-Conjugating Enzyme Ubc9 and Promotes the Sumoylation of Its Binding Partners

Cell cycle (Georgetown, Tex.), 2005-04, Vol.4 (4), p.590-596

2005

Volltextzugriff (PDF)

The Stemness Phenotype Model

ISRN oncology, 2012, Vol.2012 (2012), p.1-10

2012

Volltextzugriff (PDF)

A melanoma-associated germline mutation in exon 1β inactivates p14ARF

Oncogene, 2001-09, Vol.20 (39), p.5543-5547

2001

Volltextzugriff (PDF)

Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains Unchanged

ISRN oncology, 2011-01, Vol.2011 (2011), p.1-14

2011

Volltextzugriff (PDF)

Differentiation of cucumber mosaic virus isolates using the polymerase chain reaction

Journal of general virology, 1992-08, Vol.73 (8), p.2099-2103

1992

Volltextzugriff (PDF)

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Annals of oncology, 2019-05, Vol.30 (5), p.815

2019

Volltextzugriff (PDF)

Enforced Expression of p14ARF Induces p53-Dependent Cell Cycle Arrest but Not Apoptosis

Cell cycle (Georgetown, Tex.), 2005-03, Vol.4 (3), p.465-472

2005

Volltextzugriff (PDF)

Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.8542-8542

2011

Volltextzugriff (PDF)

1 – 25 von 297

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(255)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor

Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma

The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma

Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS

Pre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

PO-368 Differential effects of immune activity on melanoma cell subtypes

Uveal melanoma cell lines depend on multiple signaling pathways for survival

21P - Uveal melanoma cell lines depend on multiple signaling pathways for survival

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization

21PUveal melanoma cell lines depend on multiple signaling pathways for survival

Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding

Impaired inhibition of NF-κB activity by melanoma-associated p16INK4a mutations

1861PPre-treatment circulating cytokines predict toxicity with combination anti-PD1 and anti-CTLA4 immunotherapy

Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma

A Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D+T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)

p14ARF Interacts with the SUMO-Conjugating Enzyme Ubc9 and Promotes the Sumoylation of Its Binding Partners

The Stemness Phenotype Model

A melanoma-associated germline mutation in exon 1β inactivates p14ARF

Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains Unchanged

Differentiation of cucumber mosaic virus isolates using the polymerase chain reaction

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients

Enforced Expression of p14ARF Induces p53-Dependent Cell Cycle Arrest but Not Apoptosis

Morphologic and immunohistochemical (IHC) changes in metastatic melanoma (MM) tissue and associations with clinical outcome in patients (pts) on BRAF inhibitors (BRAFi)

Suchergebnisse filtern